CERo Therapeutics Received A Letter From Nasdaq Notifying The Company That It Had Not Regained Compliance With The MVLS Requirement Within The Cure Period; Nasdaq Has Determined To Delist The Company's Securities From Nasdaq On November 8, 2024; On...

Benzinga11/02 05:11

CERo Therapeutics Announces Submission Of IND Clinical Hold Complete Response Letter; Adjusts Previous Guidance About Potential Entry Into The Clinic From 2024 To Early 2025; Recently Disclosed Our Cash Balance Of $3.2M As Of September 30, 2024

Benzinga10/21 21:05

CERo Therapeutics, Inc. Provides Corporate Update

GlobeNewswire10/21 21:00

12 Health Care Stocks Moving In Friday's After-Market Session

Benzinga10/19 04:30

CERo Therapeutics Shares Are Trading Lower. The Company Announced a Change in CFO.

Benzinga10/03 01:01

CERo Therapeutics Gets New Finance Head

Seeking Alpha10/02 22:25